Date | Time | Source | Announcement |
---|---|---|---|
25 Mar 2014 | 07:00 AM | Half Yearly Report | |
17 Feb 2014 | 09:34 AM | Notice of Results | |
11 Feb 2014 | 12:15 PM | Holding(s) in Company | |
03 Feb 2014 | 03:26 PM | Holding(s) in Company | |
03 Feb 2014 | 02:43 PM | Holding(s) in Company | |
27 Jan 2014 | 07:00 AM | Directorate Change | |
07 Jan 2014 | 02:12 PM | Directors' Shareholdings | |
06 Jan 2014 | 04:33 PM | Additional Listing | |
18 Dec 2013 | 12:46 PM | Result of AGM | |
18 Dec 2013 | 07:00 AM | Re Agreement | |
16 Dec 2013 | 03:36 PM | Additional Listing | |
03 Dec 2013 | 01:30 PM | Director/PDMR Shareholding | |
26 Nov 2013 | 04:27 PM | Additional Listing | |
26 Nov 2013 | 07:00 AM | Annual Report & Accounts and Notice of AGM | |
22 Oct 2013 | 07:00 AM | Final Results | |
11 Oct 2013 | 08:49 AM | Directorate Change | |
07 Oct 2013 | 08:29 AM | Director/PDMR Shareholding | |
01 Oct 2013 | 01:06 PM | Preliminary Results Date | |
09 Sep 2013 | 07:00 AM | Trading Update | |
23 Aug 2013 | 02:38 PM | Holding(s) in Company | |
08 Aug 2013 | 03:09 PM | Holding(s) in Company | |
08 Aug 2013 | 07:00 AM | EPISTEM RECEIVES PRESTIGIOUS FP7 GRANT AWARD | |
01 Aug 2013 | 07:00 AM | Trading Update | |
01 Jul 2013 | 04:04 PM | Director/PDMR Shareholding | |
29 May 2013 | 03:29 PM | Holding(s) in Company | |
15 Apr 2013 | 01:39 PM | Holding(s) in Company | |
08 Apr 2013 | 04:08 PM | Director/PDMR Shareholding | |
26 Mar 2013 | 07:01 AM | Senior Executive Incentive Package | |
26 Mar 2013 | 07:00 AM | Half Yearly Report | |
01 Mar 2013 | 10:06 AM | Notice of Results | |
22 Feb 2013 | 09:13 AM | Additional Listing | |
20 Feb 2013 | 09:39 AM | Holding(s) in Company | |
20 Feb 2013 | 09:35 AM | Holding(s) in Company | |
10 Jan 2013 | 04:36 PM | Director/PDMR Shareholding | |
09 Jan 2013 | 02:26 PM | Holding(s) in Company | |
17 Dec 2012 | 06:13 PM | Director/PDMR Shareholding | |
13 Dec 2012 | 03:24 PM | Result of AGM | |
10 Dec 2012 | 09:45 AM | Holding(s) in Company | |
07 Dec 2012 | 01:00 PM | Cash Placing | |
21 Nov 2012 | 08:18 AM | Annual Report & Accounts and Notice of AGM | |
25 Oct 2012 | 10:54 AM | Holding(s) in Company | |
24 Oct 2012 | 12:19 PM | Holding(s) in Company | |
24 Oct 2012 | 09:51 AM | Holding(s) in Company | |
16 Oct 2012 | 07:00 AM | Final Results | |
04 Oct 2012 | 03:55 PM | Director/PDMR Shareholding | |
10 Sep 2012 | 03:19 PM | Preliminary Results Date | |
06 Aug 2012 | 07:00 AM | Pre-Close Trading Update | |
03 Aug 2012 | 11:58 AM | Professor Chris Potten | |
27 Jul 2012 | 04:09 PM | Director's Shareholding and Additional Listing | |
10 Jul 2012 | 09:17 AM | Director/PDMR Shareholding |
Genedrive plc is a medical equipment company based in Manchester, UK that develops and sells point-of-care molecular diagnostic platforms. Their products are used in healthcare settings, particularly in emergency medicine, for patient stratification and disease detection. Genedrive's goal is to improve clinical outcomes with easy-to-use tests.
Genedrive's major products include:
Genedrive CYP2C19 ID Kit: A rapid test that establishes metaboliser status in time-critical settings
Genedrive MT-RNR1 ID Kit: The world's first point-of-care genetic test to reduce the risk of aminoglycoside induced hearing loss
Genedrive was founded on contract research services for pharmaceutical and biotech companies, and was originally named Epistem Holdings Inc. when it was floated on the London AIM market in 2007. The company was renamed genedrive plc in 2016 to reflect its new focus on molecular diagnostics, and divested its contract research services divisions in 2018.
GDR share price launched at 129p in 2007.